Darovasertib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Darovasertib, covering 2026-01-27 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma [Phase 2]